BioCentury
ARTICLE | Clinical News

Intradose-CDDP: Expanded Phase I/II study

August 16, 1993 7:00 AM UTC

Matrix Pharmaceutical Inc. (MATX) Product: Intradose-CDDP directly injectable collagen containing cancer drugs epinephrine and cisplatin Indication: Cancer Status: Expanded Phase I/II study to inclu...